Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,095 | -4,863 | -5,367 | -8,141 | -3,983 |
| Depreciation Amortization | 104 | 125 | 122 | 107 | 91 |
| Accounts payable and accrued liabilities | 227 | -481 | N/A | N/A | N/A |
| Other Working Capital | 227 | -370 | 225 | 253 | 54 |
| Other Operating Activity | 198 | -295 | -1,286 | 2,655 | 90 |
| Operating Cash Flow | $-1,339 | $-5,884 | $-6,306 | $-5,126 | $-3,748 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -2,599 | N/A |
| PPE Investments | N/A | -34 | -175 | -77 | -304 |
| Sale Of Investment | N/A | N/A | 3,735 | N/A | 730 |
| Purchase Sale Intangibles | -125 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -125 | 3 | 97 | 5,586 | -5,110 |
| Investing Cash Flow | $-125 | $-31 | $3,657 | $2,910 | $-4,684 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,979 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 6,479 | 3,405 | 4,562 | 9,083 |
| Other Financing Activity | -191 | -151 | 0 | 0 | 0 |
| Financing Cash Flow | $1,788 | $6,328 | $3,405 | $4,562 | $9,083 |
| Exchange Rate Effect | N/A | -327 | 332 | -196 | -35 |
| Beginning Cash Position | N/A | 5,153 | 3,664 | 1,811 | 1,018 |
| End Cash Position | 324 | 5,239 | 4,752 | 3,961 | 1,634 |
| Net Cash Flow | $324 | $86 | $1,088 | $2,150 | $616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,339 | -5,884 | -6,306 | -5,126 | -3,748 |
| Capital Expenditure | N/A | -36 | -175 | -77 | -329 |
| Free Cash Flow | -1,339 | -5,920 | -6,481 | -5,203 | -4,077 |